PPT1 and neuronal ceroid lipofuscinosis: This has allowed us not only to compare and contrast the early onset and rapid progression (typified by CLN1) vs. late onset and slow progression (CLN3) disease modalities, but these are also two of the most common and best documented disease courses among the NCL diseases, both in patients as well as in animal models of NCLs.